Poseida Therapeutics
PSTX
HK$73.89
Share price
0.00%
Change (1 day)
195.98%
Change (1 year)
Poseida Therapeutics (PSTX) - Cash on Hand
Cash on Hand as of September 2024 : HK$1.79 Billion
According to Poseida Therapeutics's latest financial reports the company has HK$1.79 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Poseida Therapeutics - Cash on Hand chart (from 2019 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | HK$1.65 B | -24.91% |
| 2022-12-31 | HK$2.20 B | 37.19% |
| 2021-12-31 | HK$1.60 B | -32.87% |
| 2020-12-31 | HK$2.39 B | 145.56% |
| 2019-12-31 | HK$0.97 B | 310.04% |
| 2018-12-31 | HK$0.23 B | 94.97% |
| 2017-12-31 | HK$0.12 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | HK$1.99 B | 10.88% | 🇺🇸 USA |